Secondly, while we examined the effects of PRKG2 on lung cancer cells and the expression of PRKG2 in fibroblasts from lung tissues of SSc-ILD patients, we did not evaluate the effects of PRKG2 in SSc animal models, an aspect we plan to address in future research. This evidence concerns the gene PRKG2 and interstitial lung disease.